• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25 filed by Merrimack Pharmaceuticals Inc.

    5/10/24 4:45:35 PM ET
    $MACK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $MACK alert in real time by email
    25 1 d838859d25.htm FORM 25 Form 25

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 25

     

     

    NOTIFICATION OF REMOVAL FROM LISTING

    AND/OR REGISTRATION UNDER SECTION 12(b)

    OF THE SECURITIES EXCHANGE ACT OF 1934.

    Commission File No. 001-35409

     

     

    Issuer: Merrimack Pharmaceuticals, Inc.

    Exchange: Nasdaq Capital Market

    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

     

     

    One Broadway, 14th Floor

    Cambridge, MA 02142

    (617) 720-8606

    (Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)

    Common stock, par value $0.01 per share

    (Description of class of securities)

     

     

    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

     

    ☐

    17 CFR 240.12d2-2(a)(1)

     

    ☐

    17 CFR 240.12d2-2(a)(2)

     

    ☐

    17 CFR 240.12d2-2(a)(3)

     

    ☐

    17 CFR 240.12d2-2(a)(4)

     

    ☐

    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1

     

    ☒

    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

     

    1 

    Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

    Pursuant to the requirements of the Securities Exchange Act of 1934, Merrimack Pharmaceuticals, Inc. (Name of Issuer or Exchange) certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

     

    MERRIMACK PHARMACEUTICALS, INC.

    By:   /s/ Gary L. Crocker
    Name:   Gary L. Crocker
    Title:   President and Chairman of the Board

    Date: May 10, 2024

     

     

     

    Get the next $MACK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MACK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MACK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Andersen Eric bought $651,754 worth of shares (49,550 units at $13.15) (SEC Form 4)

      4 - MERRIMACK PHARMACEUTICALS INC (0001274792) (Issuer)

      12/28/23 4:05:12 PM ET
      $MACK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Andersen Eric bought $1,298,472 worth of shares (101,050 units at $12.85) (SEC Form 4)

      4 - MERRIMACK PHARMACEUTICALS INC (0001274792) (Issuer)

      12/11/23 4:05:08 PM ET
      $MACK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Andersen Eric bought $3,750 worth of shares (300 units at $12.50) (SEC Form 4)

      4 - MERRIMACK PHARMACEUTICALS INC (0001274792) (Issuer)

      11/20/23 6:59:37 PM ET
      $MACK
      Biotechnology: Pharmaceutical Preparations
      Health Care